Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Anteris Technologies Global Corp. ( (AVR) ) is now available.
On April 28, 2026, Anteris Technologies Global Corp., via its subsidiary, elected to discontinue further development contributions under its April 18, 2023 Contribution and Stock Purchase Agreement with v2vmedtech, inc., after completing Stage 1 and during Stage 2 of the program. As part of this decision, Anteris must pay v2v a $400,000 break fee to support continued technology development, and the related Development Agreement will terminate upon payment.
Following the notice, Anteris has no further funding obligations to v2v, while v2v’s initial shareholders may either buy out Anteris’ entire equity stake for the amount of its aggregate contributions to date or dilute it to a capped minority stake as set out in the agreement. The company has indicated it does not expect this withdrawal and the termination of the development arrangements to have a material adverse effect on its consolidated financial position or liquidity, suggesting limited balance-sheet impact from the strategic pullback.
The most recent analyst rating on (AVR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Anteris Technologies Global Corp. stock, see the AVR Stock Forecast page.
Spark’s Take on AVR Stock
According to Spark, TipRanks’ AI Analyst, AVR is a Neutral.
The score is primarily held down by very weak financial performance (declining revenue, large recurring losses, negative equity, and heavy cash burn). Technicals are neutral and provide limited support, while valuation is constrained by losses and lack of dividend. A positive operational event (new facility lease with abatements) helps modestly but does not offset the elevated financing risk.
To see Spark’s full report on AVR stock, click here.
More about Anteris Technologies Global Corp.
Anteris Technologies Global Corp., through its wholly owned subsidiary Anteris Technologies Corporation, operates in the medical technology sector, pursuing development-stage collaborations to advance specialized healthcare technologies. The company structures its investments via staged contribution agreements that can be scaled back or exited based on predefined milestones and strategic considerations.
Average Trading Volume: 917,943
Technical Sentiment Signal: Hold
Current Market Cap: $550.3M
For detailed information about AVR stock, go to TipRanks’ Stock Analysis page.